Founder & Clinical Director
Clinical leadership you can name
Independent evaluation only carries weight when a credible clinician stands behind it. Our founder and Clinical Director does.
Dr Muhammad Suffyan Rasheed
Founder & Clinical Director, Meds Global Health. Dr Rasheed founded Meds Global Health to bring clinical rigour to the way healthcare adopts AI, data and digital tools. He combines frontline medical experience with clinical-safety and evaluation expertise, and personally oversees the standards behind our advisory, validation and educational work.
Meds Global Health is led together with co-founder Ahmad Qazi, who oversees the company's technology, product and growth. The pairing is deliberate: clinical judgement and engineering discipline in the same room, so the tools and evidence we produce are both clinically sound and well built.
A detailed CV, professional registration details and references are available to prospective clients, partners and event organisers on request — get in touch.
Why it matters
Independent evaluation needs a name behind it
When a trust, a board or a regulator weighs whether to trust an assessment, they are really asking who stands behind it. Anonymous, process-only assurance carries little weight in healthcare. Meds Global Health is built on the opposite principle: a named, accountable clinician owns the clinical standard, and that accountability runs through every safety case, validation report and piece of education we produce. It is what lets a buyer act on our findings with confidence — and what keeps us honest about the limits of what the evidence shows.
How clinical oversight works here
- Standards are set centrally. The Clinical Director defines the methodology and quality bar for clinical safety, AI validation, evidence and education, captured in our quality & editorial policy.
- Work is delivered to that standard. The core team and, where needed, vetted specialists from our expert network deliver under the same governance — never a different bar for different projects.
- Clinical outputs are reviewed and signed off. Anything that carries clinical weight is checked under clinical direction before it reaches you, with sources and assumptions made explicit.
- Limits are stated plainly. We are clear about what an evaluation can and cannot conclude — because over-claiming is itself a safety risk.
A two-founder model
Dr Rasheed leads the clinical side; co-founder Ahmad Qazi leads technology, product and growth. That division means our clinical tools, AI validation and data work are designed by people who understand both the medicine and the engineering — and that neither the clinical nor the technical standard is ever an afterthought. It also keeps the company small, senior and directly accountable: when you work with us, you work with the people who set the standards.
Answers
Frequently asked questions
Who leads the clinical work?
Our Clinical Director leads clinical safety, evaluation methodology and content review across the company, ensuring every clinical output meets a consistent standard.
Can the founder speak at our event?
Yes — we accept selected speaking and advisory enquiries on clinical AI, safety and digital-health adoption. Use the contact form with the details of your event.
How can I obtain a full CV or credentials?
We are happy to share a detailed CV, professional registration details and references directly with prospective clients, partners and event organisers on request — just get in touch and tell us what you need it for.
Is a clinician involved in every piece of work?
Yes. Clinical safety, evaluation and education work is led and signed off under clinical direction, not delegated to non-clinical staff. The Clinical Director sets the standards and reviews the outputs that carry clinical weight.
Who do we contract with?
You contract with Meds Global Health. Work is delivered by the core team and, where a specific specialty is needed, by vetted clinicians from our expert network under the same clinical governance.
Invite the founder, or start a project
For talks, advisory or a proposal, we'd love to hear from you.